ArticleRSC advances2020

A novel series of phenolic temozolomide (TMZ) esters with 4 to 5-fold increased potency, compared to TMZ, against glioma cells irrespective of MGMT expression.

Leroy Shervington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.